# Zenas BioPharma

Zenas BioPharma is an Asset Manager based in Waltham, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Waltham, United States
- **Region:** North America
- **Address:** 852 Winter Street Suite 250, Waltham, MA 02451, United States
- **Assets under management:** Undisclosed
- **Website:** www.zenasbio.com
- **LinkedIn:** https://www.linkedin.com/company/zenas-biopharma

## Regulatory record

- **Reports private funds:** No

## About

Enabling patients with autoimmune diseases to reimagine life

## Sectors

- Biotechnology
- Immunology

## People

- Lonnie Moulder — Chief Executive Officer and Chairman of the Board of Directors

## Questions

### Who makes investment decisions at Zenas BioPharma?

Lonnie Moulder serves as CEO and Chairman, leading corporate strategy and development. The board includes executives such as Patricia Allen, James Boylan, Patrick Enright, Hongbo Lu, Jake Nunn, and John Orloff. (per firm website)

### What is Zenas BioPharma's primary therapeutic focus?

The firm concentrates exclusively on autoimmune diseases with significant unmet medical need. Its two lead candidates target B-cell activity and BTK pathways to address multiple indications. (per firm website)

## Related profiles

- [Kamada Ltd.](https://altss.com/profile/kamada-ltd)
- [Quigley Eye Specialists](https://altss.com/profile/quigley-eye-specialists)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/zenas-biopharma

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology